We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
An image displaying a Newsletter on tablet, laptop & mobile

To continue reading this article, sign up for FREE to

Technology Networks logo


Membership is FREE and provides you with instant access to email newsletters, digital publications, our full content catalogue & more...

Identification of Urinary Biomarkers of Colon Inflammation in IL10-/-Mice Using Short-Column LCMS Metabolomics

Read time: Less than a minute

The interleukin-10-deficient mouse develops colon inflammation in response to normal intestinal microflora and has been used as a model of Crohn’s disease.

Three differential metabolites were identified by this study as xanthurenic acid and as the glucuronides of xanthurenic acid and of α-CEHC (2,5,7,8- tetramethyl-2-(2 -carboxyethyl)-6-hydroxychroman). The significance of several differential metabolites as potential biomarkers of colon inflammation was evaluated in an experiment which compared metabolite concentrations in IL10−/− and WT mice housed, either under conventional conditions and dosed with intestinal microflora, or maintained under specific pathogen-free (SPF) conditions. Concentrations of xanthurenic acid, α-CEHC glucuronide, and an unidentified metabolite m/z 495−/497+ were associated with the degree of inflammation in IL10−/− mice and may prove useful as biomarkers of colon inflammation.

The full article is published online within the Journal of Biomedicine and Biotechnology and is free to access.

Google News Preferred Source Add Technology Networks as a preferred Google source to see more of our trusted coverage.